Treatment Claims, Evidence and Choices During the Pandemic: The Case of Covid-19 in Africa
Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
This presentation is in partnership with the Global Engagement Institute.
- Differentiate between trustworthy and untrustworthy claims regarding the coronavirus.
- Use evidence-based medicine to treat coronavirus.
Recording date: March 24, 2021
Date of original release: March 24, 2021
Most recent review/update: March 24, 2021
Termination date: March 23, 2024
Michael Mugisha, PT, MPH, PhD(c)
Mr. Mugisha works at the University of Rwanda on research and teaching roles. He is currently the Program Manager for Research and Capacity Development at the University of Rwanda. Michael has led various research projects that involve multiple stakeholders both local and international. He has been involved in designing and implementing various public health research projects. Michael has good management skills of complex projects that require task sharing among multiple stakeholders. He has financial management skills where he managed CDC-PEPFAR and EU funded Implementation Science Research. He has a good track record in steering collaborations with local teams from Ministry of Health, Rwanda Biomedical Center, Rwanda Education Board and various NGOs, through joint research activities.
Mr. Mugisha lectures the Health Measurement and Research module and unit courses of Biostatistics and Epidemiology to students from the College of Medicine and Health Sciences in undergraduate and postgraduate. He is interested in academic and research work related to design, development, implementation and evaluation of innovations applied in health to improve health outcomes in low resource settings.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individuals have no financial conflicts with commercial interest companies to disclose:
- Michael Mugisha - Speaker
- Sondra Schreiber - Activity Director
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2B
- 1.00 CE Contact Hour(s)
- 1.00 IBON